TRSO
Transuite.Org Inc.Substantial doubt about the company's ability to continue as a going concern.
“The Company's ability to continue as a going concern is contingent upon achieving future profitable operations and securing sufficient financing to meet operational obligations.”View the 10-Q filed Jun 16, 2026
One customer — 100% of receivables (As of December 31, 2025)
“As of December 31, 2025, one customer represented 100% of the outstanding accounts receivable balance of $19,299.”
3 customers — 62.7% of receivables (As of March 31, 2026)
“As of March 31, 2026 three customers represented 62.7%, 19.7% and 17.5% of the outstanding accounts receivable balance $120,781.”
3 customers — 55.5% of revenue (the three months ended March 31, 2026)
“For the three months ended March 31, 2026, the Company generated total revenue of $121,784 of which three customers accounted for 55.5%, 23.6% and 20.9% of the Company’s total revenue.”
3 customers — 23.6% of revenue (the three months ended March 31, 2026)
“For the three months ended March 31, 2026, the Company generated total revenue of $121,784 of which three customers accounted for 55.5%, 23.6% and 20.9% of the Company’s total revenue.”
3 customers — 20.9% of revenue (the three months ended March 31, 2026)
“For the three months ended March 31, 2026, the Company generated total revenue of $121,784 of which three customers accounted for 55.5%, 23.6% and 20.9% of the Company’s total revenue.”
3 customers — 19.7% of receivables (As of March 31, 2026)
“As of March 31, 2026 three customers represented 62.7%, 19.7% and 17.5% of the outstanding accounts receivable balance $120,781.”
3 customers — 17.5% of receivables (As of March 31, 2026)
“As of March 31, 2026 three customers represented 62.7%, 19.7% and 17.5% of the outstanding accounts receivable balance $120,781.”
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
No Investor Relations Content
No press releases or events have been collected for this stock yet.